Title Created Date
Side-chain modified vitamin D analogs require activation of both PI 3-K and erk1,2 signal transduction pathways to induce differentiation of human promyelocytic leukemia cells 18 September 2014
Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study 11 September 2014
Octreotide treatment of patients with hepatocellular carcinoma--a retrospective single centre controlled study 10 September 2014
The effects of melatonin on human hepatoma (Hep G2) cell line 10 September 2014
Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1 03 September 2014
Interactions of vitamin D analogue CB1093, TNFalpha and ceramide on breast cancer cell apoptosis 03 September 2014
Human leukemic (HMC-1) mast cells are responsive to 1alpha, 25-dihydroxyvitamin D(3): selective promotion of ICAM-3 expression and constitutive presence of vitamin D(3) receptor 03 September 2014
Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin 01 September 2014
Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3 29 August 2014
Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism 26 August 2014
Display #